|
Market Closed -
Nasdaq
04:00:00 2026-03-13 pm EDT
|
After hours
04:55:32 pm
|
|
366.21 USD
|
-0.43%
|
 |
368.02 |
+0.50%
|
|
Mar. 12 |
GRAIL, Inc. Announces Board Changes
|
CI
| |
Mar. 12 |
GRAIL, Inc. Announces Chief Executive Officer Changes, Effective June 1, 2026
|
CI
| |
Mar. 12 |
Grail CEO Bob Ragusa to retire, Josh Ofman named successor
|
RE
| |
Mar. 11 |
Amgen Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-11-2026 09:20 AM
| | |
Mar. 10 |
Equinix, Inc. Appoints Olivier Leonetti as Chief Financial Officer, Effective March 16, 2026
|
CI
| |
Mar. 09 |
Global drugmakers rush to boost US presence as tariff threat looms
|
RE
| |
Mar. 09 |
LB Pharmaceuticals Inc Appoints Robert Lenz, M.D., Ph.D. to Board of Directors
|
CI
| |
Mar. 05 |
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE
|
PR
| |
Mar. 05 |
Arcutis Biotherapeutics, Inc. Announces Promotion of Mas Matsuda to Executive Vice President, Chief Legal Officer, and Corporate Secretary
|
CI
| |
Mar. 05 |
Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset
|
CI
| |
Mar. 04 |
Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15
|
MT
| |
Mar. 04 |
Amgen announces 2026 second quarter dividend
|
RE
| |
Mar. 04 |
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND
|
PR
| |
Mar. 04 |
Amgen Announces 2026 Second Quarter Dividend, Payable on June 5, 2026
|
CI
| |
Mar. 04 |
Tivic Health Systems, Inc. Announces CEO Changes
|
CI
| |
Mar. 04 |
Tivic Health Systems, Inc. Announces Board Changes
|
CI
| |
Mar. 04 |
NervGen Pharma Corp. Announces Executive Changes
|
CI
| |
Mar. 03 |
PRF Technologies Ltd. Announces CEO Changes, Effective February 25, 2026
|
CI
| |
Mar. 03 |
Absci Corporation Announces Executive Changes
|
CI
| |
Mar. 03 |
Kyowa Kirin stops development of skin condition treatment
|
RE
| |
Mar. 03 |
Kyowa Kirin announces discontinuation of Rocatinlimab clinical trials
|
RE
| |
Mar. 03 |
Kyowa Kirin Co., Ltd. Discontinues All Ongoing Clinical Trials for Rocatinlimab
|
CI
| |
Mar. 02 |
Amgen Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 01:10 PM
| | |
Mar. 01 |
Fujian Haixi Pharmaceuticals Co., Ltd. Appoints Dr. Zhang Mingqiang as President of Research & Development and Global Affairs, Effective March 1, 2026
|
CI
| |
Feb. 27 |
Generate Biomedicines shares fall in weak Nasdaq debut for drug developer
|
RE
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
